Clinical trial
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
NCT00041938
Study timeline
Study start (unknown)2002-10-01Date precision: month
Registry last updated2014-09-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Diseaseunresolved
Strokeunresolved
Ischemic Heart Diseaseunresolved
Myocardial Infarctionunresolved
Interventions
aspirinDRUG · verified · RxNorm: aspirin
WarfarinDRUG · verified · RxNorm: warfarin
Sponsors & collaborators
Columbia Universitylead sponsor
Mapped research locations
PhiladelphiaPennsylvania, United States4New YorkNew York, United States3MiamiFlorida, United States2MontrealQuebec, Canada2DenverColorado, United States2TucsonArizona, United States2LouisvilleKentucky, United States2BuffaloNew York, United States2HoustonTexas, United States1ChicagoIllinois, United States1AtlantaGeorgia, United States1TorontoOntario, Canada1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00041938 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.